Clinical trial
Treatment and Outcomes Among Patients With Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment and Outcomes Among Patients With Atrial Fibrillation and Acute Coronary Syndrome in Sweden
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 16, 2017
- Completion date
- March 23, 2018
- Enrollment
- 14,226 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.